Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement

Robert P. Baughman, Marjolein Drent, Mani S. Kavuru, +13

American Journal of Respiratory and Critical Care Medicine

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis

Thomas J. Richards, Naftali Kaminski, Fred Baribaud, +10

American Journal of Respiratory and Critical Care Medicine

Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

Kristian Reich, April W. Armstrong, Richard G. Langley, +6

The Lancet

Systemic TreatmentGuselkumab Versus SecukinumabClinical DermatologyPharmacotherapyDermatology +4

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase <scp>III NAVIGATE</scp> trial

Richard G. Langley, Tsen‐Fang Tsai, Susan Flavin, +6

British Journal of Dermatology

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

Marc A. Judson, Robert P. Baughman, Ulrich Costabel, +4

European Respiratory Journal

CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab

Ganesh Raghu, Fernando J. Martínez, Kevin K. Brown, +12

European Respiratory Journal

Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy

Robert P. Baughman, Ralph T. Shipley, Sujal R. Desai, +9

CHEST Journal

Chest RoentgenogramSarcoidosis PatientsInfliximab TherapyMedicineCardiology +1

Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.

Robert P. Baughman, Marc A. Judson, Elyse E. Lower, +5

PubMed

Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis

Matthew J. Loza, Carrie Brodmerkel, Roland M. du Bois, +8

Clinical and Vaccine Immunology

Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study

Philip E. Silkoff, Susan Flavin, Robert Gordon, +20

Journal of Allergy and Clinical Immunology

AsthmaImmunologyAntiviral ResponseToll-like Receptor 3Virology +3